Rakovina Therapeutics Inc. RKV.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.21% | 10.07% | -9.45% | 40.77% | -37.93% |
| Total Depreciation and Amortization | 2.35% | 0.00% | -0.10% | 1.55% | 4.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.52% | 158.83% | -72.60% | 1,098.58% | -83.22% |
| Change in Net Operating Assets | -52.74% | -53.95% | 1,358.75% | 124.85% | -154.98% |
| Cash from Operations | -51.65% | -38.40% | 50.04% | 65.66% | -153.96% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -89.50% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -265.27% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 801.15% | 94.09% | -- |
| Cash from Financing | -30.14% | -- | 100.00% | -100.53% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -233.16% | 155.74% | 51.23% | -158.95% | 251.54% |